New Canada Post stamps honour medical contributions of six Canadians

Canada Post has issued a set of five commemorative stamps to honour the contributions made in the medical field by six Canadian physicians and researchers; Drs. Bruce Chown, Julio Montaner, Balfour Mount, M. Vera Peters, James Till and Ernest McCulloch.

“Their contributions to the fields of pediatric pathology, HIV/AIDS, palliative care, oncology and stem cell science changed the practice of medicine in Canada and around the world,” Canada Post said in a statement on Monday.

According to the press release; Dr. Chown was a world leader in eliminating rhesus disease, once a major cause of newborn deaths, Dr. Montaner helped transform HIV and AIDS into being manageable conditions, Dr. Mount founded the world’s first palliative care service based in a teaching hospital, Dr. Peters completely changed treatment of Hodgkin’s Lymphoma and breast cancer, and Dr. Till and Dr. McCulloch created the foundations of stem cell science.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below